FOTEMUSTINE for Metastatic malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where FOTEMUSTINE was used for Metastatic malignant melanoma.
Most Reported Side Effects for FOTEMUSTINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 66 | 25.0% | 9 | 16 |
| Disease progression | 38 | 14.4% | 8 | 0 |
| Acute myeloid leukaemia | 30 | 11.4% | 4 | 8 |
| Thrombocytopenia | 29 | 11.0% | 6 | 15 |
| Mucosal inflammation | 25 | 9.5% | 5 | 10 |
| Neutropenia | 24 | 9.1% | 6 | 10 |
| Product use in unapproved indication | 23 | 8.7% | 1 | 12 |
| Platelet count decreased | 22 | 8.3% | 1 | 1 |
| Neutrophil count decreased | 20 | 7.6% | 0 | 1 |
| Septic shock | 20 | 7.6% | 3 | 11 |
| White blood cell count decreased | 20 | 7.6% | 1 | 0 |
| Diffuse large b-cell lymphoma | 17 | 6.4% | 0 | 0 |
| Diffuse large b-cell lymphoma recurrent | 17 | 6.4% | 0 | 0 |
| Drug ineffective | 17 | 6.4% | 2 | 3 |
| Vomiting | 17 | 6.4% | 6 | 8 |
Other Indications for FOTEMUSTINE
Diffuse large b-cell lymphoma (77)
Bone marrow conditioning regimen (21)
Non-hodgkin's lymphoma (20)
Autologous bone marrow transplantation therapy (14)
Glioblastoma (14)
Diffuse large b-cell lymphoma stage iv (12)
Stem cell transplant (10)
Intraocular melanoma (8)
Product used for unknown indication (8)
Allogenic bone marrow transplantation therapy (6)
Other Drugs Used for Metastatic malignant melanoma
NIVOLUMAB (4,628)
IPILIMUMAB (4,430)
DABRAFENIB (3,885)
PEMBROLIZUMAB (2,742)
TRAMETINIB DIMETHYL SULFOXIDE (2,031)
VEMURAFENIB (1,848)
TRAMETINIB (1,604)
COBIMETINIB (898)
ENCORAFENIB (865)
BINIMETINIB (841)